To evaluate the role of the PI3K/Akt pathway in p21/CDKN1A expression in CTet-treated breast cancer cell lines, Akt activity was detected by using a specific anti-phospo-Akt antibody, the phosphorylated form of Akt protein. This evidence concerns the gene CDKN1A and breast cancer.